Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 211–225 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5655 ATL1 Gene (SPG3A) Next‑Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants in the ATL1 gene associated with autosomal dominant hereditary spastic paraplegia type 3A (SPG3A).	Peripheral whole blood, extracted DNA, or DNA FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATL1 gene", "Coverage of coding and deep intronic regions"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected hereditary spastic paraplegia type 3A", "Family history of SPG3A"] Measurement technique Confirm with laboratory Codes LOINC: 21656-8 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the ATL1 gene associated with autosomal dominant hereditary spastic paraplegia type 3A (SPG3A).
TEST-5478 ATL1 Gene Neuropathy, Hereditary Sensory, Type 1D Genetic Test This genetic test analyzes the ATL1 gene to identify mutations associated with Hereditary Sensory Neuropathy Type 1D (HSN1D). It detects single nucleotide variants, insertions, del...	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATL1 gene sequence", "Mutations in ATL1 gene (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "No specific medication or diet restrictions"] Indications ["Clinical suspicion of Hereditary Sensory Neuropathy Type 1D (HSN1D)", "Family history of HSN1D"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G60.8 Clinical summary This genetic test analyzes the ATL1 gene to identify mutations associated with Hereditary Sensory Neuropathy Type 1D (HSN1D). It detects single nucleotide variants, insertions, deletions, and copy number variations within the gene.
TEST-5381 ATL3 Gene Hereditary Sensory Neuropathy Type 1F (HSN1F) Genetic Test This test identifies pathogenic variants in the ATL3 gene associated with Hereditary Sensory Neuropathy Type 1F (HSN1F). It uses Next-Generation Sequencing (NGS) and Sanger confirm...	Whole blood (EDTA), extracted DNA, or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATL3 gene", "Full coding region plus ±5 bp flanking intronic sequences"] Parameters [] Preparation ["Fasting is not required", "Maintain usual routine"] Indications ["Suspected Hereditary Sensory Neuropathy Type 1F (HSN1F)", "Autosomal dominant sensory neuropathy"] Measurement technique Confirm with laboratory Codes LOINC: 82287-9 ICD-10: G60.8 Clinical summary This test identifies pathogenic variants in the ATL3 gene associated with Hereditary Sensory Neuropathy Type 1F (HSN1F). It uses Next-Generation Sequencing (NGS) and Sanger confirmation for high diagnostic sensitivity.
TEST-4202 ATN1 Gene Dentatorubral-Pallidoluysian Atrophy (DRPLA) Genetic Test This test detects abnormal CAG repeat expansions within the ATN1 gene, confirming a diagnosis of Dentatorubral-Pallidoluysian Atrophy (DRPLA).	Whole blood (EDTA), extracted DNA, or FTA card (dried blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATN1 gene CAG repeat expansion size"] Parameters [] Preparation ["No fasting or special preparation is needed", "A mandatory genetic counselling session is required"] Indications ["Suspected DRPLA based on clinical symptoms", "Family history of DRPLA", "Genetic counselling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G11.8 Clinical summary This test detects abnormal CAG repeat expansions within the ATN1 gene, confirming a diagnosis of Dentatorubral-Pallidoluysian Atrophy (DRPLA).
TEST-3918 ATP10A Gene Sequencing (NGS) Test This test evaluates the ATP10A gene for variants associated with neurodevelopmental disorders.	Peripheral Whole Blood, Saliva	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP10A gene sequence", "Single-nucleotide variants (SNVs)", "Small insertions or deletions (indels)"] Parameters [] Preparation ["No specific fasting required.", "Inform phlebotomist of any medications."] Indications ["Suspected genetic cause of neurodevelopmental delay", "Diagnosis of ASD", "Diagnosis of intellectual disability", "Diagnosis of Angelman syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 94835-8 ICD-10: Z13.71, F84.0, Q93.5 Clinical summary This test evaluates the ATP10A gene for variants associated with neurodevelopmental disorders.
TEST-5440 ATP13A2 (PARK9) Gene Genetic Test This test evaluates the ATP13A2 gene for pathogenic variants associated with Kufor-Rakeb syndrome and early-onset Parkinson disease.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP13A2 gene sequence", "Pathogenic variants", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No specific fasting required.", "Inform phlebotomist of all current medications."] Indications ["Diagnosis of Kufor-Rakeb syndrome", "Diagnosis of early-onset Parkinson disease", "Genetic counseling for families with ATP13A2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81321-3 ICD-10: G23.8, G20 Clinical summary This test evaluates the ATP13A2 gene for pathogenic variants associated with Kufor-Rakeb syndrome and early-onset Parkinson disease.
TEST-4406 ATP1A2 Gene Familial Hemiplegic Migraine Type 2 Genetic Test This genetic test identifies pathogenic variants in the ATP1A2 gene associated with Familial Hemiplegic Migraine Type 2.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card	3–4 weeks (from sample receipt at laboratory)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP1A2 gene sequence", "Copy Number Variations (CNVs) in ATP1A2"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Suspected diagnosis of Familial Hemiplegic Migraine Type 2", "Family history of FHM2", "Genetic counseling for migraine disorders"] Measurement technique Confirm with laboratory Codes LOINC: 48000-6 ICD-10: G43.1, G43.10, G43.11 Clinical summary This genetic test identifies pathogenic variants in the ATP1A2 gene associated with Familial Hemiplegic Migraine Type 2.
TEST-3764 ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 (AHC2) Genetic Test This test evaluates the ATP1A3 gene for pathogenic variants associated with Alternating Hemiplegia of Childhood type 2 (AHC2). It uses Next-Generation Sequencing (NGS) to detect va...	Whole Blood (EDTA tube), Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP1A3 gene sequence", "Pathogenic variants (point mutations, indels, copy number changes)"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Diagnosis of Alternating Hemiplegia of Childhood type 2", "Genetic confirmation", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 98995-9 ICD-10: G24.3 Clinical summary This test evaluates the ATP1A3 gene for pathogenic variants associated with Alternating Hemiplegia of Childhood type 2 (AHC2). It uses Next-Generation Sequencing (NGS) to detect various mutation types.
TEST-3882 ATP1B4 Gene Genetic Test (Autism Spectrum Disorder) This test detects pathogenic variants in the ATP1B4 gene associated with autism spectrum disorder.	Peripheral whole blood (3–5 mL in EDTA tube); also accepts extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic single-nucleotide variants in ATP1B4", "Small indels in ATP1B4"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected genetic cause of autism spectrum disorder", "Family history of autism spectrum disorder", "Pre-test pedigree analysis suggests ATP1B4 involvement"] Measurement technique Confirm with laboratory Codes LOINC: 94219-7 ICD-10: F84.0, F84.9 Clinical summary This test detects pathogenic variants in the ATP1B4 gene associated with autism spectrum disorder.
TEST-5438 ATP2A2 Gene Genetic Test for Acrokeratosis Verruciformis (Darier Disease) This genetic test identifies mutations in the ATP2A2 gene associated with Darier disease (acrokeratosis verruciformis).	Whole blood (EDTA), dried blood spot on FTA card, or extracted genomic DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP2A2 gene sequence", "Pathogenic variants", "Copy number variations (CNV) within the ATP2A2 gene"] Parameters [] Preparation [] Indications ["Suspected Darier disease", "Family history of Darier disease", "Prenatal or preimplantation genetic diagnosis after identifying a familial variant"] Measurement technique Confirm with laboratory Codes LOINC: 94222-8 ICD-10: Q82.8 Clinical summary This genetic test identifies mutations in the ATP2A2 gene associated with Darier disease (acrokeratosis verruciformis).
TEST-5844 ATP2B3 Gene Spinocerebellar Ataxia Type 1 (X‑Linked) Genetic Test This genetic test evaluates the ATP2B3 gene for mutations associated with X-linked spinocerebellar ataxia type 1.	Peripheral whole blood (EDTA tube), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP2B3 gene sequence", "Copy Number Variations (CNV) in ATP2B3 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Clinical suspicion of X-linked spinocerebellar ataxia type 1", "Family history of X-linked ataxia", "Carrier testing for female relatives", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21643-9 ICD-10: G11.8, Z14.8, Z82.79 Clinical summary This genetic test evaluates the ATP2B3 gene for mutations associated with X-linked spinocerebellar ataxia type 1.
TEST-6251 ATP5F1A Gene Combined Oxidative Phosphorylation Deficiency Type 22 Genetic Test This test identifies pathogenic variants in the ATP5F1A gene associated with combined oxidative phosphorylation deficiency type 22 (COXPD22). It uses Next-Generation Sequencing (NG...	Whole Blood (EDTA tube), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP5F1A gene variants", "Single nucleotide variants", "Small insertions and deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Avoid blood transfusion within 2 weeks prior to sample collection"] Indications ["Suspected combined oxidative phosphorylation deficiency type 22 (COXPD22)", "Early-onset metabolic disorder with neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 90507-4 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the ATP5F1A gene associated with combined oxidative phosphorylation deficiency type 22 (COXPD22). It uses Next-Generation Sequencing (NGS) to analyze the entire coding region and flanking splice sites.
TEST-5083 ATP5F1A Gene Sequencing for Mitochondrial Complex V Deficiency, Nuclear Type 4 (NGS) Test This test evaluates the ATP5F1A gene for mutations associated with mitochondrial complex V deficiency, nuclear type 4.	Peripheral whole blood (EDTA) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP5F1A gene coding region", "Pathogenic variants"] Parameters [] Preparation ["Fasting is not required", "Mandatory genetic counselling session prior to sample collection"] Indications ["Suspected mitochondrial complex V deficiency, nuclear type 4", "Progressive neurological symptoms of unknown origin"] Measurement technique Confirm with laboratory Codes LOINC: 94891-5 ICD-10: E88.49 Clinical summary This test evaluates the ATP5F1A gene for mutations associated with mitochondrial complex V deficiency, nuclear type 4.
TEST-5182 ATP5F1E Gene Test This diagnostic test evaluates the ATP5F1E gene for pathogenic variants associated with Mitochondrial Complex V (ATP Synthase) Deficiency, Nuclear Type 3.	Whole Blood (EDTA Tube), Extracted DNA (≥1 µg), or Dried Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATP5F1E gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (Indels)", "Copy number variations (CNVs)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "≥99.9% for SNVs and Indels"}] Preparation ["A mandatory Genetic Counselling session is required prior to sample processing.", "Document a pedigree chart of family members affected with ATP5F1E-related Mitochondrial Complex V Deficiency, Nuclear Type 3."] Indications ["Suspected Mitochondrial Complex V Deficiency, Nuclear Type 3", "Neonatal or early-childhood onset hypotonia", "Lactic acidosis", "Hypertrophic cardiomyopathy", "Developmental regression"] Measurement technique Confirm with laboratory Codes LOINC: 93495-7 ICD-10: E88.49, G31.82, Z13.71 Clinical summary This diagnostic test evaluates the ATP5F1E gene for pathogenic variants associated with Mitochondrial Complex V (ATP Synthase) Deficiency, Nuclear Type 3.
TEST-4965 ATP6AP2 Gene NGS Test (X‑Linked Intellectual Disability & Epilepsy) This test evaluates the ATP6AP2 gene for pathogenic variants associated with X-linked intellectual disability and epilepsy.	Whole blood, extracted DNA, or one-drop FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP6AP2 gene sequence", "Pathogenic variants in coding regions and splice sites"] Parameters [] Preparation ["A clinical history must be documented", "A comprehensive pedigree chart must be drawn", "Pre-test genetic counselling session is mandatory", "Avoid supplements or medications that could interfere with DNA quality"] Indications ["Individuals with early-onset epilepsy and intellectual disability of unknown cause", "Carrier screening in female relatives of affected males"] Measurement technique Confirm with laboratory Codes LOINC: 79294-9 ICD-10: Z13.73 Clinical summary This test evaluates the ATP6AP2 gene for pathogenic variants associated with X-linked intellectual disability and epilepsy.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories